Doctors and nurses on duty from COVID-19 protest against the North MCD administration for alleged non-payment of outstanding wages, at the Hindu Rao Hospital in New Delhi, on Friday, October 9, 2020 (Express photo by Amit Mehra) .
Meanwhile, a handful of coronavirus vaccine candidates are nearing the end of late-stage clinical trials. At least two vaccine pioneers, Pfizer and Moderna Inc, are set to publish late-stage and Phase 2 results this month.
While experts have said the vaccines are likely to reach the general public between March and April 2021, drug makers have been more ambitious with their calculations, and some companies like Moderna Inc are considering the use authorization route. emergency to launch their vaccines before the end of the year. In fact, Pfizer could also apply for approval of its vaccine by the US FDA this month, Bloomberg reported.
There are 182 vaccine candidates in clinical or preclinical trials around the world. Of these, 36 are in clinical trials and nine are in final stages of human trials. In India, where two vaccines are in phase II trials and Oxford’s in phase III, the Union Ministry of Health has said it expects supplies to be available from January next year.
.
